Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking and Finance Review - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Private equity firm Advent to sell generic drugmaker Zentiva to GTCR
    Finance

    Private equity firm Advent to sell generic drugmaker Zentiva to GTCR

    Published by Global Banking and Finance Review

    Posted on September 11, 2025

    1 min read

    Last updated: January 21, 2026

    Private equity firm Advent to sell generic drugmaker Zentiva to GTCR - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:private equityinvestmentfinancial servicescorporate governanceCapital Markets

    Quick Summary

    Advent International sells Zentiva to GTCR for over €4 billion, marking a significant transaction in the pharmaceutical industry.

    Table of Contents

    • Overview of the Zentiva Acquisition
    • Details of the Deal
    • Background on Zentiva
    • Market Implications

    Advent International to Divest Zentiva to GTCR for Over €4 Billion

    Overview of the Zentiva Acquisition

    (Reuters) - Czech generic drugmaker Zentiva said on Thursday that private equity group Advent International had agreed to sell the company to rival GTCR for an undisclosed value.

    Details of the Deal

    The deal values the Prague-based company at slightly more than 4 billion euros ($4.69 billion) including debt, according to a source with knowledge of the deal.

    Background on Zentiva

    The Financial Times had first reported the deal on Wednesday, saying it was worth 4.1 billion euros.

    Market Implications

    Zentiva was acquired by Advent from French pharmaceutical giant Sanofi in 2018 for an enterprise value of 1.9 billion euros.

    There have been reports of Advent mulling a sale of the generics drugmaker since 2021, with companies such as Polish drugmaker Polpharma and India's Aurobindo Pharma reported to be joining the race.

    Zentiva supplies a wide range of generic and over-the-counter drugs such as paracetamol and co-codamol to more than 100 million people across Europe.

    ($1 = 0.8530 euros)

    (Reporting by Unnamalai L in Bengaluru and Andres Gonzalez Estebaran; Editing by Maju Samuel)

    Key Takeaways

    • •Advent International sells Zentiva to GTCR.
    • •The deal values Zentiva at over €4 billion.
    • •Zentiva was acquired by Advent from Sanofi in 2018.
    • •Zentiva supplies generic drugs across Europe.
    • •The sale has been anticipated since 2021.

    Frequently Asked Questions about Private equity firm Advent to sell generic drugmaker Zentiva to GTCR

    1What is private equity?

    Private equity refers to investment funds that buy and restructure companies that are not publicly traded, often aiming to improve their financial performance before selling them for a profit.

    2What is an acquisition?

    An acquisition is a corporate action in which one company purchases most or all of another company's shares to gain control of that company.

    3What are corporate governance practices?

    Corporate governance practices involve the systems and processes that direct and control a company, ensuring accountability, fairness, and transparency in its relationship with stakeholders.

    4What is capital markets?

    Capital markets are financial markets where long-term debt or equity-backed securities are bought and sold, providing companies with access to capital for growth.

    5What is a financial service?

    Financial services encompass a broad range of services provided by the finance industry, including banking, investment, insurance, and asset management.

    More from Finance

    Explore more articles in the Finance category

    Image for Dollar holds gains on economic data, Fed bets; Aussie jumps on RBA hike
    Dollar holds gains on economic data, Fed bets; Aussie jumps on RBA hike
    Image for Asian stocks up; Aussie rallies after rate hike
    Asian stocks up; Aussie rallies after rate hike
    Image for Oil falls on possible US-Iran de-escalation, firm dollar
    Oil falls on possible US-Iran de-escalation, firm dollar
    Image for Activist shareholder ACCR, pension funds urge BP to show shift to oil and gas will deliver value
    Activist shareholder ACCR, pension funds urge BP to show shift to oil and gas will deliver value
    Image for Google Cloud, Liberty Global strike five-year AI partnership
    Google Cloud, Liberty Global strike five-year AI partnership
    Image for EU proposals set to limit EV sales from 2035, says campaign group
    EU proposals set to limit EV sales from 2035, says campaign group
    Image for Metals, crude oil dive in broad commodities market tumble
    Metals, crude oil dive in broad commodities market tumble
    Image for Trading Day: Solid data over hard assets
    Trading Day: Solid data over hard assets
    Image for Exclusive-OpenAI is unsatisfied with some Nvidia chips and looking for alternatives, sources say
    Exclusive-OpenAI is unsatisfied with some Nvidia chips and looking for alternatives, sources say
    Image for Crypto market volatility triggers $2.5 billion in bitcoin liquidations
    Crypto market volatility triggers $2.5 billion in bitcoin liquidations
    Image for Germany's ProSiebenSat.1 Media reports lower revenue for 2025
    Germany's ProSiebenSat.1 Media reports lower revenue for 2025
    Image for Germany's BayWa in talks with financiers and shareholders on possible changes to restructuring process
    Germany's BayWa in talks with financiers and shareholders on possible changes to restructuring process
    View All Finance Posts
    Previous Finance PostTrump envoy tells Belarus: We want to reopen our embassy in Minsk soon and normalise ties
    Next Finance PostM&S digital chief exits months after damaging hack